Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China

Leukemia and Lymphoma

Volumn 49, Issue 3, 2008, Pages 488-494

  Gu, Long Jun ^a   Li, Juan ^a   Xue, Hui Liang ^a   Tang, Jing Yan ^a   Chen, Jing ^a   Zhao, Hui Jun ^a   Ye, Hui ^a   Pan, Ci ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute; ALL XH 99 protocol; Childhood; EFS; Leukemia; Lymphoblastic

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CHINA; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEALTH CARE COST; HUMAN; KAPLAN MEIER METHOD; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPEATED DRUG DOSE; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHINA; DAUNORUBICIN; FEMALE; HEALTH CARE COSTS; HUMANS; IDARUBICIN; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RECURRENCE; REMISSION INDUCTION; RISK ASSESSMENT; TREATMENT OUTCOME; VINCRISTINE;

EID: 39749185937     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701784730     Document Type: Article

References (28)

1. Long, Jun Gu (1999) Treatment of childhood acute leukemia with regular standard protocol to improve long-term disease free survival rate. Chinese J Hematol, 20, pp. 341-342.
2. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. and Gralnick, H. R. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol, 33, pp. 451-458.
3. Berg, A van der Does-van den, Bartram, C. R., Basso, G., Benoit, Y. C., Biondi, A. and Debatin, K. M. (1992) Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol, 20, pp. 497-505.
4. Ludwig, W. D., Rieder, H., Bartram, C. R., Heinze, B., Schwartz, S. and Gassmann, W. (1998) Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89. Blood, 92, pp. 1898-1909.
5. Bene, M. C., Castoldi, G., Knapp, W., Ludwig, W. D., Matutes, E. and Orfao, A. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, pp. 1783-1786.
6. Harbott, J., Ritterbach, J., Ludwig, W-D, Bartram, C. R., Reiter, A. and Lampert, F. (1993) Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: Experience of the BFM trials. Recent Results Cancer Res, 131, pp. 123-132.
7. ISCN 1995 (1995) An International System for Human Cytogenetic Nomenclature, Karger, Basel
8. Tsurusawa, M., Katano, N. and Fujimoto, T. (1990) Prognosis and DNA aneuploidy in children with acute lymphoblastic leukemia. Haematol Blood Transfus, 33, pp. 174-181.
9. Hui, Ye, Long-jun, Gu, Jing, Chen, Hui-liang, Xue, Yuhong, Tong and Juan, Qian (2000) Approach on CF protocol after high-dose MTX vein drop. Chinese J Hematol, 21, pp. 92-93.
10. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53, pp. 457-481.
11. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, pp. 163-170.
12. Pui, C-H, Boyett, J. M., Rivera, G. K., Hancock, M. L., Sandlund, J. T. and Ribeiro, R. C. (2000) Long-term results of total therapy studies 11, 12 and 13A for childhood acute leukemia at St Jude Children's Research Hospital. Leukemia, 14, pp. 2286-2294.
13. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W. D. and Henze, G. (2000) Long-term results of four consecutive trials in childhood ALL. Performed by the ALL-BFM study group from 1981 to 1995. Leukemia, 14, pp. 2205-2222.
14. Gaynon, P. S., Trigg, M. E., Heerema, N. A., Sensel, M. G., Sather, H. N. and Hammond, G. D. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983 - 1995. Leukemia, 14, pp. 2223-2233.
15. Eden, O. B., Harrsion, G., Richards, S., Lilleyman, J. S., Bailey, C. C. and Chessells, J. M. (2000) Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukemia, 1980 - 1997. Medical Research Council Childhood Leukaemia Working Party. Leukemia, 14, pp. 2307-2320.
16. Harms, D. O. and Janka-Schaub, G. E. (2000) Co-operative study of the childhood acute lymphoblastic leukemia (COALL): Long-term follow-up trials 82, 85, 89, and 92. Leukemia, 14, pp. 2234-2239.
17. Tsuchida, M., Ikuta, K., Hanada, R., Saito, T., Isoyama, K. and Sugita, K. (2000) Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981 - 1995. Leukemia, 14, pp. 2295-2306.
18. Pui, C. H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K. and Ribeiro, R. C. (2004) Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood, 104, pp. 2690-2696.
19. Jun, Gu Long, Hui-yu, Yao, Hui-liang, Xue, Huijun, Zhao, Yaoping, Wang and Meiyu, Gu (1994) Clinical result of 57 cases of childhood acute lymphoblastic leukemia treated with ALL-XH-88 protocol of early continuous intensified chemotherapy. Chinese J Hematol, 15, pp. 76-79.
20. Pui, C. H., Simone, J. V., Hancock, M. L., Evans, W. E., Williams, D. L. and Bowman, W. P. (1992) Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: Long-term results of St. Jude Total Therapy Study X. Leukemia, 6, pp. 150-157.
21. Masson, E., Relling, M. V., Synold, T. W., Liu, Q., Schuetz, J. D. and Sandlund, J. T. (1996) Accumulation of methotrexate polyglutamates in lymphoblasts is determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest, 97, pp. 73-80.
22. Reiter, A., Schrappe, M., Ludwig, W. D., Hiddemann, W., Sauter, S. and Henze, G. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84, pp. 3122-3133.
23. Lange, B. J., Bostrom, B. C., Cherlow, J. M., Sensel, M. G., La, M. K. and Rackoff, W. (2002) Double delayed intensification improves EFS for children with intermediate risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood, 99, pp. 825-833.
24. Pui, C-H and Evans, W. E. (2006) Treatment for acute lymphoblastic leukemia. N Engl J Med, 354, pp. 166-178.
25. Schrappe, M., Reiter, A., Ludwig, W. D., Harbott, J., Zimmermann, M. and Hiddemann, W. (2000) Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: Results of trial ALL-BFM 90. Blood, 95, pp. 3310-3322.
26. Pui, C-H, Campana, D. and Evans, W. E. (2001) Childhood acute lymphoblastic leukemia current status and future perspectives. Lancet Oncol, 2, pp. 597-607.
27. Gaynon, P. S., Desai, A. A., Bostrom, B. C., Hutchinson, R. J., Lange, B. J. and Nachman, J. B. (1997) Early response to therapy and outcome in childhood acute lymphoblastic leukemia. Cancer, 80, pp. 1717-1726.
28. Moghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L. and Hurwitz, C. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, pp. 896-904.